Design Therapeutics (DSGN)
NASDAQ:DSGN
Design Therapeutics (DSGN) Ownership Overview
17.10% Insiders
5.61% Mutual Funds
33.58% Other Institutional Investors
5.60% ETFs
38.11% Public Companies and
Individual Investors
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 44.79% of the company’s stock is owned by Institutional Investors, 17.10% is owned by Insiders, and 38.11% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 14, 2025 | xxxxxxxxxxxxx | $2953792 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $8855085 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $11066683 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $13707753 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $20946468 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,526,476 | Insider | 10.58% | 67,222,703 | |
| 3,655,000 | Insider | 5.93% | 37,646,500 | |
| 2,233,099 | Institution | 3.62% | 23,000,920 | |
| 1,461,381 | Institution | 2.37% | 15,052,224 | |
| 1,439,027 | Institution | 2.33% | 14,821,978 | |
| 1,267,706 | Institution | 2.06% | 13,057,372 | |
| 1,257,517 | Institution | 2.04% | 12,952,425 | |
| 1,179,817 | Institution | 1.91% | 12,152,115 | |
| 944,039 | Institution | 1.53% | 9,723,602 | |
| 616,831 | Institution | 1.00% | 6,353,359 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,267,706 | Institution | 2.06% | 13,057,372 | |
| 616,831 | Institution | 1.00% | 6,353,359 | |
| 289,632 | Institution | 0.47% | 2,983,210 | |
| 264,662 | Institution | 0.43% | 2,726,019 | |
| 262,830 | Institution | 0.43% | 2,707,149 | |
| 134,866 | Institution | 0.22% | 1,389,120 | |
| 104,423 | Institution | 0.17% | 1,075,557 | |
| 74,501 | Institution | 0.12% | 767,360 | |
| 70,000 | Institution | 0.11% | 721,000 | |
| 67,624 | Institution | 0.11% | 696,527 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 984,775 | Institution | 1.60% | 10,281,051 | |
| 615,757 | Institution | 1.00% | 6,342,297 | |
| 316,272 | Institution | 0.51% | 3,301,880 | |
| 224,848 | Institution | 0.36% | 2,315,934 | |
| 203,985 | Institution | 0.33% | 2,101,046 | |
| 146,795 | Institution | 0.24% | 1,511,989 | |
| 140,244 | Institution | 0.23% | 1,548,294 | |
| 139,723 | Institution | 0.23% | 1,439,147 | |
| 118,002 | Institution | 0.19% | 1,231,941 | |
| 77,533 | Institution | 0.13% | 798,590 |
FAQ
Who Owns Design Therapeutics (DSGN)?
According to the latest TipRanks data, approximately 33.58% of the company's stock is held by institutional investors, 17.10% is held by insiders, and 38.11% is held by retail investors.
What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.58% of Design Therapeutics (DSGN) stock is held by institutional investors.
What percentage of Design Therapeutics (DSGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.11% of Design Therapeutics (DSGN) stock is held by retail investors.
Who owns the most shares of Design Therapeutics (DSGN)?
Simeon George owns the most shares of Design Therapeutics (DSGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.